Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Similar articles for PubMed (Select 17164975)

1.

Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme.

Martinez R, Schackert G, Yaya-Tur R, Rojas-Marcos I, Herman JG, Esteller M.

J Neurooncol. 2007 May;83(1):91-3. Epub 2006 Dec 13.

PMID:
17164975
2.

MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.

Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK.

Pediatr Blood Cancer. 2007 Apr;48(4):403-7.

PMID:
16609952
3.

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.

Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA.

Int J Cancer. 2007 Dec 1;121(11):2458-64.

PMID:
17691113
4.

Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.

Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.

Cancer Invest. 2009 Oct;27(8):825-9. doi: 10.1080/07357900902783211.

PMID:
19544111
5.

Determination of the methylation status of MGMT in different regions within glioblastoma multiforme.

Hamilton MG, Roldán G, Magliocco A, McIntyre JB, Parney I, Easaw JC.

J Neurooncol. 2011 Apr;102(2):255-60. doi: 10.1007/s11060-010-0307-5. Epub 2010 Jul 21.

PMID:
20652362
6.

Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.

Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.

Int J Oncol. 2008 Sep;33(3):469-75.

PMID:
18695875
7.

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas.

Cao VT, Jung TY, Jung S, Jin SG, Moon KS, Kim IY, Kang SS, Park CS, Lee KH, Chae HJ.

Neurosurgery. 2009 Nov;65(5):866-75; discussion 875. doi: 10.1227/01.NEU.0000357325.90347.A1.

PMID:
19834398
8.

Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma.

Parkinson JF, Wheeler HR, Clarkson A, McKenzie CA, Biggs MT, Little NS, Cook RJ, Messina M, Robinson BG, McDonald KL.

J Neurooncol. 2008 Mar;87(1):71-8. Epub 2007 Nov 15.

PMID:
18004504
9.

[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma].

Kamoshima Y, Motegi H, Terasaka S, Kobayashi H, Yamaguchi S, Murata J, Tanaka S, Houkin K.

No Shinkei Geka. 2012 Feb;40(2):129-35. Japanese.

PMID:
22281465
10.

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

Preusser M, Charles Janzer R, Felsberg J, Reifenberger G, Hamou MF, Diserens AC, Stupp R, Gorlia T, Marosi C, Heinzl H, Hainfellner JA, Hegi M.

Brain Pathol. 2008 Oct;18(4):520-32. doi: 10.1111/j.1750-3639.2008.00153.x. Epub 2008 Apr 8.

PMID:
18400046
11.

Long-term survival with glioblastoma multiforme.

Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G; German Glioma Network.

Brain. 2007 Oct;130(Pt 10):2596-606. Epub 2007 Sep 4. Review.

12.
13.

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.

Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR.

Neuroimage. 2010 Jan 15;49(2):1398-405. doi: 10.1016/j.neuroimage.2009.09.049. Epub 2009 Sep 28.

PMID:
19796694
14.

Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients.

Tang K, Jin Q, Yan W, Zhang W, You G, Liu Y, Jiang T.

Med Oncol. 2012 Jun;29(2):1292-6. doi: 10.1007/s12032-011-9901-4. Epub 2011 Mar 11.

PMID:
21394635
15.

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival.

Das P, Puri T, Jha P, Pathak P, Joshi N, Suri V, Sharma MC, Sharma BS, Mahapatra AK, Suri A, Sarkar C.

J Clin Neurosci. 2011 Jan;18(1):66-70. doi: 10.1016/j.jocn.2010.04.050.

PMID:
20888234
16.

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M.

J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163.

17.

p15 promoter methylation - a novel prognostic marker in glioblastoma patients.

Wemmert S, Bettscheider M, Alt S, Ketter R, Kammers K, Feiden W, Steudel WI, Rahnenführer J, Urbschat S.

Int J Oncol. 2009 Jun;34(6):1743-8.

PMID:
19424593
18.

MGMT gene promoter methylation in pediatric glioblastomas.

Srivastava A, Jain A, Jha P, Suri V, Sharma MC, Mallick S, Puri T, Gupta DK, Gupta A, Sarkar C.

Childs Nerv Syst. 2010 Nov;26(11):1613-8. doi: 10.1007/s00381-010-1214-y. Epub 2010 Jun 29.

PMID:
20585787
19.

The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.

Cecener G, Tunca B, Egeli U, Bekar A, Tezcan G, Erturk E, Bayram N, Tolunay S.

Cell Mol Neurobiol. 2012 Mar;32(2):237-44. doi: 10.1007/s10571-011-9753-7. Epub 2011 Sep 18.

PMID:
21928112
20.

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.

Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amistà P, Morandi L, Spagnolli F, Ermani M.

J Clin Oncol. 2009 Mar 10;27(8):1275-9. doi: 10.1200/JCO.2008.19.4969. Epub 2009 Feb 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk